HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GILLETTE FIRST QUARTER BLADES/RAZORS SALES GAIN 11.2% TO $488.3 MIL

This article was originally published in The Rose Sheet

Executive Summary

GILLETTE FIRST QUARTER BLADES/RAZORS SALES GAIN 11.2% TO $488.3 MIL worldwide, and profit from operations for the segment increased 11.2% to $188.8 mil., the company said at an April 21 securities analysts meeting. The growth was primarily in North America, where both sales and profit from operations for the category rose 20%. In Europe, sales dropped 3% due to unfavorable exchange rates, Gillette noted, adding that excluding the effect of the exchange rates, sales would have grown 4%. Profit from operations in Europe increased 2%. Blades and razors, Gillette's largest segment, generated 35.9% of total sales and contributed to the company's strong overall performance, Gillette said.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS000391

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel